| Autor: |
Krauze AV; Radiation Oncology Branch, National Cancer Institute NIH, Bethesda, MD, USA. andra.oprea@gmail.com., Attia A; Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, TN, USA., Braunstein S; Department of Radiation Oncology, University of California, San Francisco, USA., Chan M; Department of Radiation Oncology, Wake Forest Baptist Medical Center, Winston-Salem, NC, USA., Combs SE; Department of Radiation Oncology, Technical University of Munich (TUM), Munich, Germany.; Institute of Innovative Radiotherapy (iRT), Department of Radiation Sciences (DRS), Helmholtz Zentrum München, Neuherberg, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK) Partner Size, Munich, Germany., Fietkau R; Department of Radiotherapy Erlangen, Erlangen, Germany., Fiveash J; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Flickinger J; UPMC Presbyterian-Shadyside, Pittsburgh, PA, USA., Grosu A; Department of Radiation Oncology, University of Freiburg, Freiburg, Germany., Howard S; Department of Human Oncology, University of Wisconsin, Madison, WI, USA., Nieder C; Department of Oncology and Palliative Medicine, Hospital Trust, 8092, Bodø, Nordland, Norway.; Department of Clinical Medicine, Faculty of Health Sciences, University of Tromsø, 9038, Tromsø, Norway., Niyazi M; Department of Radiation Oncology, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Rowe L; Radiation Oncology Branch, National Cancer Institute, NIH, Bethesda, MD, USA., Smart DD; Radiation Oncology Branch, National Cancer Institute, NIH, Bethesda, MD, USA., Tsien C; Department of Radiation Oncology, Washington University, St. Louis, MO, USA., Camphausen K; Radiation Oncology Branch, National Cancer Institute, NIH, Bethesda, MD, USA. |
